2010 Chicago Multidisciplinary Symposium in Thoracic Oncology
Click here to go to the previous page
Program Code:
160
Date:
Friday, December 10, 2010
DISCUSSANT(S):
Click the plus sign to see more detailed information
about each speaker.
I am a Radiation Oncologist with a strong interest in clinical and translational research. After initial training in Internal Medicine and Clinical Oncology the UK, I spent two years on the Faculty at the Department of Radiation Oncology at Stanford University|University before taking up my current position as Radiation Oncologist at Peter MacCallum Cancer Centre. I am an Associate Professor at the |University of Melbourne and Chair the RANZCR Research Committee in Radiation Oncology. One of my major interests has been the role of PET scanning in patients who are candidates for Radiation Therapy. In collaboration with my colleague Professor Rod Hicks I have been involved in some of the first prospective studies of PET in Radiation Oncology and together we have published many papers on this topic. Current interests include RT planning using FDG-PET and studying changes in FLT uptake during the course of RT. Recent publications concern the role of FDG-PET in staging lung cancer, response assessment after chemo RT and the role of PET in RT planning. I am a member of the IAEA group that has studied PET in RT planning and we hope that our report will be published in the near future.
|
Jeffrey A. Bogart, M.D., SUNY Upstate Medical School, Syracuse, N.Y.
James R. Jett, M.D., Mayo Clinic, Rochester, Minn.
Joseph S. Friedberg, M.D., University of Pennsylvania Health System - Presbyterian, Philadelphia
MODERATOR(S):
Click the plus sign to see more detailed information
about each speaker.
I am a Radiation Oncologist with a strong interest in clinical and translational research. After initial training in Internal Medicine and Clinical Oncology the UK, I spent two years on the Faculty at the Department of Radiation Oncology at Stanford University|University before taking up my current position as Radiation Oncologist at Peter MacCallum Cancer Centre. I am an Associate Professor at the |University of Melbourne and Chair the RANZCR Research Committee in Radiation Oncology. One of my major interests has been the role of PET scanning in patients who are candidates for Radiation Therapy. In collaboration with my colleague Professor Rod Hicks I have been involved in some of the first prospective studies of PET in Radiation Oncology and together we have published many papers on this topic. Current interests include RT planning using FDG-PET and studying changes in FLT uptake during the course of RT. Recent publications concern the role of FDG-PET in staging lung cancer, response assessment after chemo RT and the role of PET in RT planning. I am a member of the IAEA group that has studied PET in RT planning and we hope that our report will be published in the near future.
|
Kemp H. Kernstine, M.D., Ph.D., City Of Hope National Medical Center, Duarte, Calif.